Nyxoah SA Files Routine 6-K Report
Ticker: NYXH · Form: 6-K · Filed: Sep 8, 2025 · CIK: 1857190
| Field | Detail |
|---|---|
| Company | Nyxoah SA (NYXH) |
| Form Type | 6-K |
| Filed Date | Sep 8, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, routine-report, foreign-private-issuer
TL;DR
NYXOAH files routine 6-K, confirming 20-F submission. No new info.
AI Summary
Nyxoah SA, a Belgian medical device company, filed a Form 6-K on September 8, 2025. This report is for the month of September 2025 and indicates the company is submitting its annual report under Form 20-F. The filing does not contain specific financial figures or operational updates beyond its routine reporting status.
Why It Matters
This filing confirms Nyxoah SA is adhering to its reporting obligations with the SEC, which is standard practice for publicly traded foreign private issuers.
Risk Assessment
Risk Level: low — This is a routine administrative filing confirming adherence to SEC reporting requirements, with no new material information disclosed.
Key Players & Entities
- Nyxoah SA (company) — Registrant
- 001-40552 (company) — SEC File Number
- 20250908 (date) — Filing Date
- September 2025 (date) — Reporting Period
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report information that Nyxoah SA is required to make public in Belgium or has made or will make public elsewhere, and to indicate that the company files its annual reports under cover of Form 20-F.
What is the filing date of this report?
The filing date of this report is September 8, 2025.
What is the reporting period for this Form 6-K?
The reporting period for this Form 6-K is the month of September 2025.
What is Nyxoah SA's SEC file number?
Nyxoah SA's SEC file number is 001-40552.
Does this filing contain specific financial results or operational updates?
No, this filing is a routine report of foreign private issuer and primarily confirms the company's reporting status and adherence to SEC regulations, without disclosing specific new financial results or operational updates.
Filing Stats: 450 words · 2 min read · ~2 pages · Grade level 18.5 · Accepted 2025-09-08 16:04:19
Filing Documents
- tm2525561d1_6k.htm (6-K) — 11KB
- tm2525561d1_ex99-1.htm (EX-99.1) — 20KB
- tm2525561_ex99-1img001.jpg (GRAPHIC) — 5KB
- 0001104659-25-088240.txt ( ) — 38KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. NYXOAH SA Date: September 8, 2025 By: /s/ John Landry Name: John Landry Title: Chief Financial Officer